Duality Advisers, LP Reata Pharmaceuticals Inc Transaction History

Duality Advisers, LP

  • $0
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022
SELL
$24.12 - $39.6 $2.99 Million - $4.9 Million
-123,844 Closed
0 $0
Q4 2021

Feb 02, 2022
BUY
$25.61 - $110.96 $3.17 Million - $13.7 Million
123,844 New
123,844 $3.27 Million
Q1 2021

May 13, 2021
SELL
$94.25 - $132.81 $386,142 - $544,122
-4,097 Closed
0 $0
Q4 2020

Feb 09, 2021
BUY
$102.03 - $184.62 $418,016 - $756,388
4,097 New
4,097 $506,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email